22 July 2021BioVaxys Technology (BIOV.C) Receives FDA Guidance, Begins Preparation of IND…Kieran Robertson BIOV.C BioVaxys Technology (BIOV.C) announced today that the US Food and Drug Administration (FDA) has provided its official Written Response to the Company’s request for a Pre-IND Type B review…